[Early invasive strategy no better than a selective invasive strategy for patients with non-ST-segment elevation acute coronary syndromes and elevated cardiac troponin T levels: long-term follow-up results of the ICTUS trial]
- PMID: 18361193
[Early invasive strategy no better than a selective invasive strategy for patients with non-ST-segment elevation acute coronary syndromes and elevated cardiac troponin T levels: long-term follow-up results of the ICTUS trial]
Abstract
Objective: To determine whether routine coronary angiography followed by revascularisation where appropriate is better than initial drug treatment in patients with non-ST-segment elevation acute coronary syndromes (nSTE-ACS) and elevated troponin T concentrations.
Design: Multicentre randomised clinical trial (www.controlled-trials. com, number: SRCTN82153174).
Method: Patients with nSTE-ACS and elevated cardiac troponin were randomly assigned to an early invasive strategy or a selective invasive strategy. The early invasive strategy consisted of coronary angiography and revascularisation as indicated within 48 hours. The selective invasive strategy consisted of initial drug therapy; catheterisation was performed if the patient developed refractory angina or recurrent ischaemia. The main endpoints were a composite of death, recurrent myocardial infarction and rehospitalisation for anginal symptoms within 3 years, and all-cause mortality within 4 years.
Results: A total of 1200 patients were enrolled from 42 hospitals in the Netherlands. The in-hospital revascularisation rate was 76% in the early invasive group and 40% in the selective invasive group. After 3 years, the cumulative rate for the composite endpoint was 30.0% in the early invasive group and 26.0% in the selective invasive group (hazard ratio 1.21; 95% CI: 0.97-1.50; p = 0.09). The 4-year all-cause mortality rate was similar in both treatment groups (7.9% vs 7.7%; p = 0.62).
Conclusion: Long-term follow-up of this trial suggests that an early invasive strategy is not better than a selective invasive strategy in patients with nSTE-ACS and elevated cardiac troponin. Therefore, implementation of either strategy is acceptable in these patients.
Republished from
-
Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.Lancet. 2007 Mar 10;369(9564):827-835. doi: 10.1016/S0140-6736(07)60410-3. Lancet. 2007. PMID: 17350451 Clinical Trial.
Similar articles
-
Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.Eur Heart J. 2009 Mar;30(6):645-54. doi: 10.1093/eurheartj/ehn438. Epub 2008 Sep 29. Eur Heart J. 2009. PMID: 18824461 Clinical Trial.
-
Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.Lancet. 2007 Mar 10;369(9564):827-835. doi: 10.1016/S0140-6736(07)60410-3. Lancet. 2007. PMID: 17350451 Clinical Trial.
-
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.Am Heart J. 2007 Apr;153(4):485-92. doi: 10.1016/j.ahj.2006.12.012. Am Heart J. 2007. PMID: 17383283 Clinical Trial.
-
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.Heart. 2012 Feb;98(3):207-13. doi: 10.1136/heartjnl-2011-300453. Epub 2011 Sep 19. Heart. 2012. PMID: 21930723 Review.
-
Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromes.Am Heart J. 2014 Oct;168(4):522-9. doi: 10.1016/j.ahj.2014.06.025. Epub 2014 Jul 13. Am Heart J. 2014. PMID: 25262262 Review.